Noradrenaline enhances the expression of the neuronal monocarboxylate transporter MCT2 by translational activation via stimulation of PI3K/Akt and the mTOR/S6K pathway

Gespeichert in:
Bibliographische Detailangaben
Titel: Noradrenaline enhances the expression of the neuronal monocarboxylate transporter MCT2 by translational activation via stimulation of PI3K/Akt and the mTOR/S6K pathway
Autoren: Chenal, J., Pellerin, L.
Publikationsjahr: 2025
Bestand: Université de Lausanne (UNIL): Serval - Serveur académique lausannois
Schlagwörter: 1-Phosphatidylinositol 3-Kinase/drug effects/*metabolism Animals Brain/*metabolism Cells, Cultured Enzyme Inhibitors/pharmacology MAP Kinase Signaling System/drug effects/physiology Mice Monocarboxylic Acid Transporters/agonists/genetics/*metabolism Neuronal Plasticity/drug effects/physiology Neurons/drug effects/*metabolism Norepinephrine/pharmacology/*physiology Phosphorylation/drug effects Protein Biosynthesis/drug effects/physiology Protein Kinases/drug effects/*metabolism Proto-Oncogene Proteins c-akt/drug effects/metabolism Ribosomal Protein S6 Kinases, 90-kDa/drug effects/metabolism Signal Transduction/drug effects/*physiology Synaptic Transmission/drug effects/physiology Up-Regulation/drug effects/physiology
Beschreibung: Monocarboxylate transporter 2 (MCT2) expression is up-regulated by noradrenaline (NA) in cultured cortical neurons via a putative but undetermined translational mechanism. Western blot analysis showed that p44/p42 mitogen-activated protein kinase (MAPK) was rapidly and strongly phosphorylated by NA treatment. NA also rapidly induced serine/threonine protein kinase from AKT virus (Akt) phosphorylation but to a lesser extent than p44/p42 MAPK. However, Akt activation persisted over a longer period. Similarly, NA induced a rapid and persistent phosphorylation of mammalian target of rapamycin (mTOR), a kinase implicated in the regulation of translation in the central nervous system. Consistent with activation of the mTOR/S6 kinase pathway, phosphorylation of the ribosomal S6 protein, a component of the translation machinery, could be observed upon treatment with NA. In parallel, it was found that the NA-induced increase in MCT2 protein was almost completely blocked by LY294002 (phosphoinositide 3-kinase inhibitor) as well as by rapamycin (mTOR inhibitor), while mitogen-activated protein kinase kinase and p38 MAPK inhibitors had much smaller effects. Taken together, these data reveal that NA induces an increase in neuronal MCT2 protein expression by a mechanism involving stimulation of phosphoinositide 3-kinase/Akt and translational activation via the mTOR/S6 kinase pathway. Moreover, considering the role of NA in synaptic plasticity, alterations in MCT2 expression as described in this study might represent an adaptation to face energy demands associated with enhanced synaptic transmission.
Publikationsart: article in journal/newspaper
Sprache: unknown
ISSN: 0022-3042
17394554
Relation: Journal of Neurochemistry; https://iris.unil.ch/handle/iris/197620; serval:BIB_BD0AAE1D5B89; 000247581300010
DOI: 10.1111/j.1471-4159.2007.04495.x
Verfügbarkeit: https://iris.unil.ch/handle/iris/197620
https://doi.org/10.1111/j.1471-4159.2007.04495.x
Dokumentencode: edsbas.A55AA2A8
Datenbank: BASE
Beschreibung
Abstract:Monocarboxylate transporter 2 (MCT2) expression is up-regulated by noradrenaline (NA) in cultured cortical neurons via a putative but undetermined translational mechanism. Western blot analysis showed that p44/p42 mitogen-activated protein kinase (MAPK) was rapidly and strongly phosphorylated by NA treatment. NA also rapidly induced serine/threonine protein kinase from AKT virus (Akt) phosphorylation but to a lesser extent than p44/p42 MAPK. However, Akt activation persisted over a longer period. Similarly, NA induced a rapid and persistent phosphorylation of mammalian target of rapamycin (mTOR), a kinase implicated in the regulation of translation in the central nervous system. Consistent with activation of the mTOR/S6 kinase pathway, phosphorylation of the ribosomal S6 protein, a component of the translation machinery, could be observed upon treatment with NA. In parallel, it was found that the NA-induced increase in MCT2 protein was almost completely blocked by LY294002 (phosphoinositide 3-kinase inhibitor) as well as by rapamycin (mTOR inhibitor), while mitogen-activated protein kinase kinase and p38 MAPK inhibitors had much smaller effects. Taken together, these data reveal that NA induces an increase in neuronal MCT2 protein expression by a mechanism involving stimulation of phosphoinositide 3-kinase/Akt and translational activation via the mTOR/S6 kinase pathway. Moreover, considering the role of NA in synaptic plasticity, alterations in MCT2 expression as described in this study might represent an adaptation to face energy demands associated with enhanced synaptic transmission.
ISSN:00223042
17394554
DOI:10.1111/j.1471-4159.2007.04495.x